Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
| In millions, except per share items | Dec-31-22 | Dec-05-22 | Dec-31-21 | Dec-05-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 | Dec-31-17 |
| | 10-K | 8-K | 10-K | 8-K | 10-K | 10-K | 10-K | 10-K |
| Revenues |
| International | | | | | | 98.0 | 97.7 | 88.7 |
| Biologics | | | | | | 65.5 | 59.7 | 62.7 |
| |
| EBITDA |
| |
| EBIT |
| |
| Mix |
| International | | | | | | 21.3% | 21.6% | 20.4% |
| Biologics | | | | | | 14.2% | 13.2% | 14.5% |
| |
| Growth |
| International | | | | | | 0.3% | 10.2% | |
| Biologics | | | | | | 9.7% | -4.8% | |
|